Elevai Labs Inc. Common S... (ELAB)
NASDAQ: ELAB
· Real-Time Price · USD
2.39
0.10 (4.37%)
At close: May 01, 2025, 3:59 PM
2.60
8.79%
After-hours: May 01, 2025, 07:59 PM EDT
Company Description
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products.
Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions.
The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021.
Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Elevai Labs Inc. Common Stock

Country | United States |
IPO Date | n/a |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 2 |
CEO | Graydon Bensler C.F.A. |
Contact Details
Address: No Address available No city data available, United States | |
Website | n/a |
Stock Details
Ticker Symbol | ELAB |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001840563 |
CUSIP Number | 28622K104 |
ISIN Number | US28622K1043 |
Employer ID | 85-1399981 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Graydon Bensler C.F.A. | Chief Executive Officer, Chief Financial Officer, Secretary & Director |
Braeden William Lichti | Executive Chairman of the Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 24, 2025 | 8-K | Current Report |
Apr 24, 2025 | 8-K | Current Report |
Apr 24, 2025 | 424B5 | Filing |
Apr 17, 2025 | 8-K | Current Report |
Apr 16, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Apr 10, 2025 | 8-K | Current Report |
Apr 08, 2025 | 8-K/A | [Amend] Current Report |
Apr 07, 2025 | 8-K | Current Report |
Apr 07, 2025 | S-1/A | [Amend] Filing |
Mar 28, 2025 | 4 | Filing |